Saved Results

No results saved yet.

Enter a patient name and hit Save on a result.

Clinical calculator summary

Leibovich Score for Renal Cell Carcinoma

The Leibovich score predicts metastasis-free survival after nephrectomy for clear cell renal cell carcinoma using pathological variables from the surgical specimen.

Evidence-based context for fast calculator use

Purpose:
Predict progression to metastatic disease after nephrectomy for ccRCC
Population:
Patients with clear cell RCC who have undergone nephrectomy with no metastases at surgery
Factors:
Pathological T stage, Regional lymph node status, Tumour size, Nuclear grade, Histologic tumour necrosis
Reference:
Leibovich et al., Cancer 2003
HomeLeibovich Score (RCC)
Pin your most used calculators here by clicking the star in the dropdown.

Leibovich Score (RCC)

Clinical Context & Background

The Leibovich Score (2003) is a standard prognostic model for patients with non-metastatic clear cell renal cell carcinoma (ccRCC) who have undergone radical nephrectomy. It uses pathologic T-stage, N-stage, tumor size, nuclear grade, and necrosis to predict the risk of metastasis.
Primary Source EvidenceLeibovich BC, Blute ML, Cheville JC, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97(7):1663-1671.
Formula Logic
Sum of points for pT, pN, Size, Grade, Necrosis.

Reference Data

Risk GroupScore5-Year Metastasis-Free Survival
Low Risk0 - 297%
Intermediate Risk3 - 581%
High Risk≥ 668% (Score 6) to < 20% (Score >10)

Clinical Workflow

Use, Interpret, And Continue The Patient Pathway

Expand for workflow guidance, limitations, examples, and related next steps.

When To Use

  • Use after nephrectomy when final pathology confirms non-metastatic clear cell renal cell carcinoma.
  • Most useful for surveillance intensity discussions and recurrence-risk communication after surgery.
  • Run alongside renal oncology pathway tools when the clinical question shifts from localized recurrence risk to metastatic systemic therapy prognosis.

How To Interpret

  • Scores 0-2 are generally low risk, 3-5 intermediate risk, and 6 or higher high risk for metastatic progression.
  • The score is driven by pathologic stage, nodal involvement, tumor size, grade, and histologic necrosis.
  • Higher scores should prompt careful review of surveillance schedule, imaging cadence, and eligibility for risk-adapted adjuvant discussions.

What To Do Next

  • Document the score with the pathologic variables used so the surveillance plan is reproducible.
  • For metastatic RCC or recurrence after nephrectomy, switch to IMDC or MSKCC/Motzer risk tools rather than using Leibovich.
  • Use the renal calculator hub to move between localized RCC prognosis, metastatic RCC risk, and systemic therapy context.

Limitations

  • Do not use as a metastatic RCC treatment-selection score.
  • Performance is best aligned with clear cell RCC after nephrectomy; non-clear cell histologies and incomplete pathology require caution.
  • The calculator supports risk communication and surveillance planning, not individualized treatment replacement.

Validated Population

Patients with surgically treated, non-metastatic clear cell renal cell carcinoma with post-nephrectomy pathology available.

Example use

A patient with pT3a clear cell RCC, pN0/Nx, tumor size under 10 cm, grade 3 disease, and necrosis present has a Leibovich score of 6, placing the case in a high-risk group where close surveillance and adjuvant-therapy context may be discussed.

Renal cancer calculator hubNavigate localized and metastatic RCC calculators together.IMDC metastatic RCC riskUse for metastatic RCC systemic therapy prognosis.SSIGN RCC scoreCompare another post-nephrectomy RCC recurrence model.MSKCC/Motzer RCC scoreHistorical metastatic RCC prognostic model.Renal prognosis panel guideRead how RCC prognosis tools fit together.

Share This Calculator

Share:

Related Tools

IMDC (Heng) Risk Criteria Calculator — Metastatic Renal Cell CarcinomaSSIGN Score (Mayo)MSKCC (Motzer) Score

Frequently Asked Questions

When should the Leibovich score be used?

Use it after nephrectomy for non-metastatic clear cell renal cell carcinoma when final pathologic stage, nodal status, size, grade, and necrosis are available.

Can Leibovich be used for metastatic RCC?

No. For metastatic RCC prognosis, use a model such as IMDC or MSKCC/Motzer in the appropriate systemic-therapy context.

Evidence-based oncology decision support. Verify with clinical guidelines.